Glucose Monitoring App Snapshot draft M E D I C A L D E V I C E O E M C O N T I N U O U S G L U C O S E M O N I T O R I N G S Y S T E M • Adapt to strict processing requirements of a secondary operation put in place to manufacture a new device model • Meet material size and thickness requirements while achieving desired color target • Overcome material unpredictability and sensitivity to heat, light and moisture • Minimize impact of supply chain instability and changes • Offered support for processing under low pressure conditions and at every stage of manufacturing • Performed extensive R&D work to consistently deliver the customer’s color target of a hard-to-achieve light gray • Effectively addressed all material challenges and sensitivities • Provided regular ‘summaries of understanding’ to keep up with changing forecasts and ordering patterns Mevopur™ Pre-color Formulation KEY REQUIREMENTS WHY AVIENT?

Versaflex - BVM Resuscitator Bag B A G - VA LV E - M A S K ( B V M ) M A N U FA C T U R E R R E S U S C I T A T O R B A G • Compatible gamma sterilization process • Achieve desired elastomeric properties • PVC-free formulation • FDA, ISO 10993, USP VI compliant • Repeatable injection molding process • Complemented customer expertise with technical support in material selection, part & tool design, and process development • Customized TPE offered customer an alternative to vinyl without sacrificing performance • Improved process efficiency and overall system costs through injection molding method Customized Versaflex™ TPE KEY REQUIREMENTS WHY AVIENT?

AU TO M O T I V E C O M P O N E N T S M A N U FA C T U R E R O U T S I D E R E A R - V I E W M I R R O R G A S K E T • Black materials with hardness 60 and shore A • UV Stabilized • Overmouldable on to PP • ROHS Compliant • Customer specified material • Utilized global reach to translate customer approved solution from Europe to India • Reduced development time as material was already qualified in Europe • Reduced import/export costs • Enabled Indian business to specify Avient as a preferred supplier Custom GLS™ Thermoplastic Elastomer KEY REQUIREMENTS WHY AVIENT?

E U R O P E A N M E D I C A L D E V I C E M A N U FA C T U R E R F A C E M A S K V E N T I L A T I O N V A L V E • ISO 9001 and USP VI compliant • Compatible with overmolding onto PP • Translucent and highly colorable • Soft touch • Provided valuable regulatory support and documentation, enabling faster internal trials and material qualification for this customer • Worked together with customer to select the best material from a broad portfolio of medical TPE grades • Trusted as a polymer supplier for multiple healthcare applications Dynaflex™ G2711 Thermoplastic Elastomer KEY REQUIREMENTS WHY AVIENT?

S E C U R I TY E Q U I P M EN T M A N U FA C TU R ER B O D Y S C A N N E R • Replace PMMA based radome material • Consistent dielectric performance across large sheet/surface area (4mm thick, 2m high) • Ultra low losses • No defects across full surface area • High resolution imaging to show small illegal objects • Formulated a custom material to match customer requirements • Reduced dielectric loss to 0.0009 • Improved image quality of body scanner with uniform dielectric performance and exceptionally low losses • Enabled scan time of 2 seconds and person throughput of 400 persons per hour, compared to 100 person throughput of conventional devices PREPERM™ PPE 260 Formulation KEY REQUIREMENTS WHY AVIENT?

Baby diaper manufactureR B A B Y D I A P E R M A N U FA C T U R E R P P N O N W O V E N M U L T I L A Y E R S • Provide slip additives with high concentrated content • Offer products meeting customer FDA requirements • Shorten supply lead time and reduce cost compared with importing from EU • Offered additives with high concentrated content, which is unachievable for competitors • Provided regulatory support, significant cost and time savings • Compressed the timeline through on-site color visualization, exploration, and formulation of new colors by the expert designer Cesa Slip Additives KEY REQUIREMENTS WHY AVIENT?

Medical gown manufacturer M E D I C A L G OW N M A N U FAC T U R E R P P N O N W O V E N M U L T I L A Y E R S • Excellent anti-microbial and anti-virus performance • Pass JIS Test • Provide technical support including specific specs, processing and molding recommendations • Customized anti-virus solutions designed to support performance standards for materials used in the surgical environment • Provided technical support for material selection, part & tool design, and process development to accelerate commercialization • Supported customer’s products pass the JIS test Cesa WithStand Antimicrobial Additives KEY REQUIREMENTS WHY AVIENT?

S I D IN G & C LA D D I N G M A N U FAC T U R E R P R O F I L E E X T R U S I O N • Achieve consistent distribution and uniform cell structure • Avoid adverse chemical reactions caused by material incompatibility with PVC formulations • Maintain impact resistance and durability • Attain thermally-stable chemical foaming agent (CFA) and gas decomposition temperatures to avoid manufacturing downtime • Ensure the integrity of color, finish, and aesthetics • Validated performance and compatibility during formulation and testing to confirm material compatibility and consistency • Established processing parameters for real- time precision in temperature, pressure, and extrusion speed • Optimized CFA and process to balance weight reduction and retain mechanical properties and aesthetics Hydrocerol Chemical Foaming Agents KEY REQUIREMENTS WHY AVIENT?

F L E X IB L E PA C K AG I N G M A N U FAC T U R E R F L E X I B L E P O U L T R Y P A C K A G I N G • Provide low friction resistance for multilayer film structures with external polyamides • Prevent self-adhesion of plastic films • Enhance the end-use appearance • Provided additives that result in a lower coefficient of friction for packaging end products • Enhanced the appearance of packaging surfaces by creating a smoother finish • Offered expertise in additives for polyamides in flexible packaging and assistance in achieving regulatory approval Cesa Anti-Block Additives and Cesa Slip Additives KEY REQUIREMENTS WHY AVIENT?

Avient corporation first quarter 2024 results and 2024 financial guidance AVIENT CORPORATION F I R S T Q U A R T E R 2 0 2 4 R E S U L T S A N D 2 0 2 4 F I N A N C I A L G U I D A N C E (NYSE: AVNT) M A Y 7 , 2 0 2 4 D I S C L A I M E R Forward-Looking Statements Certain statements contained in or incorporated by reference into this presentation constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. For the same reasons, Avient is unable to address the probable significance of the unavailable information. 2 O P E N I N G R E M A R K S 4 REGIONAL DEMAND TRENDS-TOTAL COMPANY Q 1 S A L E S V S P Y ( E X C L U D I N G F X ) 4 US & Canada Latin America EMEA Asia +2% -6% Flat +2% Avient ex. FX -1.5% FX -0.5% Total Avient -2.0% Q 1 2 0 2 4 R E S U L T S Q1 2024 PERFORMANCE VS.